|Number of pages||5|
|Journal||American Journal of Cardiology|
|State||Published - 1 Oct 2020|
Access to Document
In: American Journal of Cardiology, Vol. 132, 01.10.2020, p. 168-172.
Research output: Contribution to journal › Letter › peer-review
TY - JOUR
T1 - Drug-Eluting Stents Versus Bypass Surgery for Left Main Disease
T2 - An Updated Meta-Analysis of Randomized Controlled Trials With Long-Term Follow-Up
AU - Ahmad, Yousif
AU - Howard, James P.
AU - Arnold, Ahran D.
AU - Ali, Ziad A.
AU - Francis, Darrel
AU - Moses, Jeffrey W.
AU - Leon, Martin B.
AU - Kirtane, Ajay J.
AU - Karmpaliotis, Dimitri
AU - Stone, Gregg W.
N1 - Funding Information: ADA reports honoraria and sponsorship from Medtronic and Bayer. ZAA reports grant support from National Heart, Lung, and Blood Institute; grant support and advisory board fees from Abbott Vascular and Cardiovascular Systems Inc; and speaker fees from Amgen and Astra Zeneca; advisory board from Abiomed, advisory board and speaker fees from Boston Scientific, advisory board and speaker fees from Cardinal Health, advisory board and consultancy from Opsens Medical, advisory board from Acist Medical; and equity from Shockwave Medical. MBL reports consultancy to Abbott Vascular and Boston Scientific. AJK reports institutional funding to Columbia University and/or Cardiovascular Research Foundation from Medtronic, Boston Scientific, Abbott Vascular,Abiomed, CSI, Philips, and ReCor Medical. DK reports honoraria from Abbott Vascular, Boston Scientific, and Abiomed and holds equity in Soundbite, Saranas, and Traverse Vascular. And all other authors have no conflict of interest to declare. GWS reports having received speaker or other honoraria from Cook, Terumo, QOOL Therapeutics and Orchestra Biomed; serving as a consultant to Valfix, TherOx, Vascular Dynamics, Robocath, HeartFlow, Gore, Ablative Solutions, Miracor, Neovasc, V-Wave, Abiomed, Ancora, MAIA Pharmaceuticals, Vectorious, Reva, Matrizyme; receiving equity/options from Ancora, Qool Therapeutics, Cagent, Applied Therapeutics, Biostar family of funds, SpectraWave, Orchestra Biomed, Aria, Cardiac Success, MedFocus family of funds, Valfix.
PY - 2020/10/1
Y1 - 2020/10/1
UR - http://www.scopus.com/inward/record.url?scp=85089294300&partnerID=8YFLogxK
U2 - 10.1016/j.amjcard.2020.06.059
DO - 10.1016/j.amjcard.2020.06.059
M3 - Letter
C2 - 32718553
AN - SCOPUS:85089294300
SN - 0002-9149
VL - 132
SP - 168
EP - 172
JO - American Journal of Cardiology
JF - American Journal of Cardiology